Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5% sodium chloride bolus versus continuous infusion for correction of hyponatremia in adults with traumatic brain injury
IRCT20251208068246N1Phase 3Recruiting
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jan 2026
- Countries
- 1
01
Overview
Phase 3, single-blind trial of sodium chloride in hyponatraemia (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Plasma sodium, Urine specific gravity and 1 more. Started Jan 2026; status: recruiting.
02
Drugs
sodium chloride
03
Conditions
hyponatraemia
Beyond the preview
Go deeper on IRCT20251208068246N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251208068246N1.